Becky Johnson

Becky Johnson has worked in a variety of roles in the scientific field. From 2022 to 2020, they were a Senior Scientist at Transine Therapeutics. From 2020 to 2018, they were a Scientist 2/Senior Scientist at Horizon Discovery, where they were a project lead and part of a team to conduct pooled CRISPR screens in a wide range of cell lines. From 2018 to 2017, they were a Postdoctoral Research Associate at the University of Cambridge, where they investigated the effect of the bacterial pathogen Salmonella on gene expression within host immune cells. In 2017, they were a Research Associate at Imperial College London. Finally, from 2012 to 2013, they were a Summer Intern at the John Innes Centre, where they worked on improving the existing genome annotation of Xanthomonas campestris using RNA sequencing data.

Becky Johnson began their education in 2008 when they obtained an International Baccalaureate from The Sixth Form College, Colchester. Becky then attended the University of York from 2010-2013, where they earned a Bachelor of Science (BSc) in Biology. In 2013, they completed an MRes in Biomedical Research at Imperial College London, with a focus on Microbial Pathogenesis. Finally, they returned to Imperial College London in 2014 and completed a PhD in Life Sciences Research, with a focus on Microbial Pathogenesis, in 2017. Additionally, in November 2021, they obtained a certification in Project Management: Solving Common Project Problems from LinkedIn.